12 healthy volunteers test drug combo in Early-Stage study
NCT ID NCT07308041
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study looked at how a new GERD drug, linaprazan glurate, changes the way the body processes the antibiotic amoxicillin. Twelve healthy adults took amoxicillin alone and then again after a week of the GERD drug. The goal was to measure drug levels in the blood, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG INTERACTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CTC Clinical Trial Consultants AB
Uppsala, 752 37, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart bottle cap could reveal hidden missed doses in GERD patients
- Could a simple liquid barrier help nighttime heartburn sufferers sleep better?
- New GERD drug tegoprazan tested in large real-world study
- New heartburn drug candidate tested for heart safety in healthy volunteers
- Can a diet and lifestyle program replace acid reflux pills after achalasia surgery?
- Fat cells injected into esophagus could tame reflux without surgery